Alpa Laboratories, a company in the Pharmaceuticals industry, reported revenue of ₹31 crore and a net loss of ₹1.85 crore for the September 2026 quarter.
Alpa Laboratories (NSE: ALPA) closed at ₹49.92 on 20 Nov 2026, down 37.1% over the past year. Its market capitalisation is ₹105 crore and it trades at 50.0 times earnings.
Incorporated in 1988, Alpa Laboratories Ltd manufactures and sells Drugs and Chemicals
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.